from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1869c/-

LFCtreatmentdescriptionclass of inhibitor

1.683

Amikacinug/mL Amikacintranslation

1.970

Cap5-10ug/mL Capreomycintranslation

2.721

Rox10-50 ug/mL Roxithromycintranslation

0.852

SM2-5 ug/mL Streptomycintranslation

2.323

Tet5-10 ug/mL Tetracyclinetranslation

0.329

Rif0.2-5ug/mL Rifampicintranscription

-0.749

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.066

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.809

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.657

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.888

Clofazimine10-13 ug/mL Clofaziminerespiration

0.254

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.235

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.546

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.390

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.500

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.362

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.391

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.637

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.866

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.844

KCN5-20 ug/mL Potassium cyaniderespiration

0.268

NaN30.2-2 mM Sodium aziderespiration

0.519

Nigericin50 uM Nigericinrespiration

-0.602

TRC10-150 ug/mL Triclosanrespiration

-0.537

TRZ10-25 ug/mL Thioridazinerespiration

1.389

Valinomycin0.5-10 uM Valinomycinrespiration

1.062

ZnSO42 mM ZnSO4respiration

-0.215

menadione6-10 ug/mL Menadionerespiration

-0.501

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.183

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.149

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.423

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.577

NRP_1Non-replicating persistence stage 1dosRassociated

0.040

Amp0.2mg/mL AmpicillincellWall

0.369

Cephalexin20-100 ug/mL CephalexincellWall

-0.962

Cerulenin0.32-5 ug/mL CerulenincellWall

0.359

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.521

EMB10-20 ug/mL EthambutolcellWall

0.314

Eta12-40 ug/mL EthionamidecellWall

-0.002

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.205

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.420

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.744

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.495

BZA0.12 mg/mL BenzamidearomaticAmides

0.247

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.674

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.584

H2O24 mM hydrogen peroxideDNAdamaging

-0.223

Levo10 ug/mL LevofloxacinDNAdamaging

-0.236

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.110

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.160

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.196

UVUV-irradiationDNAdamaging

-1.427

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.287

Antimycin12.5-50 ug/mL Antimycin A?

0.218

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.371

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.259

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.957

PA8240.2-2 ug/mL PA-824?

0.619

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.604

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.228

Verapamil50 uM Verapamil?

0.240

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.339

methoxatin10-20 ug/mL Methoxatin?